Day: March 7, 2022

SAN JOSE, Calif., March 07, 2022 (GLOBE NEWSWIRE) — Credo Technology Group Holding Ltd (“Credo”) (Nasdaq: CRDO) today announced that Bill Brennan, CEO, and Dan Fleming, CFO, are scheduled to present at the following upcoming investor conference. Conference: 34th Annual Roth Conference Date: Monday, March 14, 2022 Time: 8:30 am PT Location: Dana Point, California The presentation will be webcast on Credo’s IR website at http://investors.credosemi.com/. The webcast replay will be available as soon as possible following the event on Credo’s IR website. About Credo  Credo is an innovator in providing secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. Our innovations ease system...

ATLANTA, March 07, 2022 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) has received additional limited notice to proceed (“LNTP”) for their IPMSR® process and equipment activities to be used in Cheniere’s Corpus Christi Stage Three liquefied natural gas (LNG) export terminal project. In conjunction with the LNTP, Chart booked an order of $47.5 million for the project from Bechtel. Chart will begin recognizing revenue on this project in 2022 with a multi-year staggered delivery schedule. FORWARD-LOOKING STATEMENTS Certain statements made in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning Chart’s business plans, including statements regarding objectives, future orders, revenues, margins, earnings,...

Operational Resources Strengthened in Support of Ongoing Phase 2 Clinical Trials for COVID-19 and Advanced Head & Neck Cancer ATLANTA, GA, March 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced recent key staff appointments and changes Jeffrey Welch has been appointed to serve as Head, Process Development and Manufacturing Operations (consultant).  In this role, Jeff will provide oversight and direction to enhance GeoVax’s manufacturing capacity of MVA-related products, a key element in advancing the Company’s current and upcoming clinical development programs. Jeff brings over 30 years of experience in biopharmaceutical development and CMC operations, with expertise in manufacturing...

To Nasdaq Copenhagen A/S7 March 2022Corporate Announcement No. 32/2022This is to give notice of the annual general meeting of Jyske Realkredit A/S on Monday 21 March 2022 at 8.00 a.m. at the company’s address Klampenborgvej 205 in Lyngby. Agenda a)        Report on the company’s activities in 2021; b)        Submission for approval of the annual report for 2021 and announcement of discharge for the Supervisory Board and the Executive Board from their obligations; c)     Submission for the application of profits or cover of loss according to the adopted annual report; d)    Election of members of the Supervisory Board; e)    Appointment of auditors; f)     Motion from the Supervisory Board: Capital reduction. It is proposed that the share capital be reduced by a nominal amount of DKK 3,806,480,000 at a price of 100 by allocation...